Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K35/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2020/106097COMPOSITION, COMPRISING MESENCHYMAL STEM CELLS, FOR INHIBITING ADIPOGENESIS
WO 28.05.2020
Int.Class C12N 5/0775
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
07Animal cells or tissues
071Vertebrate cells or tissues, e.g. human cells or tissues
077Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells
0775Mesenchymal stem cells; Adipose-tissue derived stem cells
Appl.No PCT/KR2019/016123 Applicant CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION Inventor KIM, Gi Jin
The present invention relates to a composition for inhibiting, preventing, alleviating, or treating adipogenesis. Mesenchymal stem cells or a composition comprising same according to an aspect can be helpfully used in the prevention, treatment, or alleviation of a disease associated with abnormality of fat metabolism by inhibiting fat accumulation or adipose tissue increase.
2.WO/2020/106366ALDEHYDE CROSSLINKING, PROTEIN BASED TISSUE SCAFFOLDS, AND USES THEREOF
WO 28.05.2020
Int.Class A61K 35/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Appl.No PCT/US2019/054010 Applicant UNIVERSITY OF FLORIDA RESEARCH FOUNDATION Inventor ALLEN, Josephine
Described herein are methods of preparing protein scaffolds that can include the step of crosslinking protein fibers in the vapor phase of a natural aldehyde, such as cinnamaldehyde or vanillin or a solution thereof. Also described herein are protein scaffolds that can be prepared by a method that can include the step of crosslinking protein fibers in the vapor phase of a natural aldehyde solution, such as cinnamaldehyde or vanillin or a solution thereof.
3.WO/2020/105705FUNCTIONAL ROCK
WO 28.05.2020
Int.Class A01N 61/00
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
61Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
Appl.No PCT/JP2019/045634 Applicant MATERRA CO., LTD. Inventor OHNO Teruo
The present disclosure provides a functional rock or a rock powder thereof, and the use of the functional rock or a rock powder thereof. In one embodiment, the present disclosure provides a powder of the functional rock having a nanoscale particle size, and a production method for the functional rock powder. In one embodiment, the present disclosure provides hygiene products, clothes, cosmetics, sebum inhibitors, medicinal products, and quasi-drugs to which the functional rock or a rock powder thereof is added. These hygiene products, clothes, cosmetics, sebum inhibitors, medicinal products, and quasi-drugs, may exhibit a microorganism inhibition effect, an anti-oxidation effect, a blood circulation promotion effect, and/or a body temperature-increasing and maintaining effect. In one embodiment, the functional rock is a volcanic rock. In one embodiment, the functional rock is rhyolite.
4.WO/2020/106075COMPOSITION FOR TREATING HAIR LOSS OR PROMOTING HAIR GROWTH
WO 28.05.2020
Int.Class A61K 35/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
16Blood plasma; Blood serum
Appl.No PCT/KR2019/016012 Applicant MEDICOSBIOTECH, INC Inventor LEE, Sang Yup
The present invention relates to a composition for treating hair loss or promoting hair growth which contains a silk protein, and plasma or serum components. According to the present invention, due to the synergistic effect of a silk protein and plasma or serum components, the effect of promoting hair growth and the effect of treating hair loss can be expected to be more efficient.
5.WO/2020/106975MANUFACTURE OF VIRUS
WO 28.05.2020
Int.Class C12N 7/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Appl.No PCT/US2019/062643 Applicant WESTERN ONCOLYTICS LTD. Inventor WRIGHT, Paul Andrew
Provided herein are methods of manufacturing viruses. Also provided herein are bioreactors comprising virus-infected host cells comprising viruses. In some aspects, the present disclosure relates to production of recombinant oncolytic viruses, e.g., recombinant vaccinia viruses.
6.WO/2020/106074PHARMACEUTICAL COMPOSITION FOR TREATING CUTS
WO 28.05.2020
Int.Class A61K 35/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
14Blood; Artificial blood
16Blood plasma; Blood serum
Appl.No PCT/KR2019/016011 Applicant MEDICOSBIOTECH, INC Inventor LEE, Sang Yup
The present invention relates to a pharmaceutical composition for treating cuts, containing a silk protein and a plasma component as active ingredients. According to the present invention, cuts can be more effectively healed by using synergistic effects of a silk protein and a plasma component.
7.WO/2020/106924ADENOVIRUSES AND METHODS FOR USING ADENOVIRUSES
WO 28.05.2020
Int.Class A61K 35/76
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
76Viruses; Subviral particles; Bacteriophages
Appl.No PCT/US2019/062547 Applicant MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH Inventor BARRY, Michael A.
This invention relates to methods and materials for nucleic acid delivery, vaccination, and/or treating cancer. More specifically, methods and materials for nucleic acid delivery, vaccination, and/or treating cancer using one or more recombinant adenoviruses (Ads) as an oncolytic agent are provided.
8.WO/2020/106743METHODS OF GENERATING MYCELIAL SCAFFOLDS AND APPLICATIONS THEREOF
WO 28.05.2020
Int.Class A01G 18/20
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
GHORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
18Cultivation of mushrooms
20Culture media, e.g. compost
Appl.No PCT/US2019/062248 Applicant ECOVATIVE DESIGN LLC Inventor BAYER, Eben
Several methods are described for generating mycelial scaffolds for use several technologies. In one embodiment, a mycelial scaffold is generated using a perfusion bioreactor system for cell-based meat technologies. In another embodiment, a mycelial scaffold is prepared for biomedical applications. The mycelial scaffolds may be generated from a liquid medium or from a solid substrate.
9.WO/2020/104802ISLET CELL ENGRAFTMENT
WO 28.05.2020
Int.Class A61K 38/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
Appl.No PCT/GB2019/053291 Applicant THE UNIVERSITY OF NOTTINGHAM Inventor SHAKESHEFF, Kevin
A composition of polymer particles, wherein the polymer particles are loaded with an agent that is capable of enhancing the binding of islet cells to liver tissue, and wherein (i) the polymer particles comprise linked molecules, wherein the linked molecules comprise:a) asialoglycoprotein receptor (ASGPR)-binding molecules that are capable of binding the asialoglycoprotein receptor (ASGPR) on a cell surface, orb) a binding- molecule that is specific for a cell surface marker that is predominantly present in liver tissue; and/or (ii) the polymer particles are between about 0.5 and about 100 microns in diameter.
10.WO/2020/106982METHODS OF OVERCOMING RESISTANCE TO IMMUNE CHECKPOINT INHIBITORS
WO 28.05.2020
Int.Class A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Appl.No PCT/US2019/062654 Applicant BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM Inventor WELSH, James
Provided herein are methods of using BMP7 levels as a marker for the selection of patients, such as non-small cell lung cancer patients, who will clinically respond to combination therapy comprising a BMP7 inhibitor and an immune checkpoint therapy, such as an anti-PD1 therapy and/or an anti-CTLA-4 therapy. Also provided are methods of treating the selected patients with a combination of a BMP7 inhibitor and an immune checkpoint therapy.